Concepedia

Jessie Hao-Ru Hsu

JH

9

Publications

837

Citations

9

H-Index

2008

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Dana-Farber Cancer Institute

University of Southern California

Harvard Stem Cell Institute

Jessie Hao-Ru Hsu is an author at AstraZeneca (United States) specializing in cell biology, molecular biology, and chemical biology.

Top concepts

Publications per year

2008–2024

9

Publications

9

Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner

Huafeng Xie, Jian Xu, Jessie Hao-Ru Hsu et al. · Cell stem cell · 2013 · 317 citations · Full text

, , +7

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson et al. · Cell chemical biology · 2019 · 192 citations · Full text

, ,

BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of <i>CDKN2A</i> Repression

Dorothea Douglas, Jessie Hao-Ru Hsu, Long Hung et al. · Cancer Research · 2008 · 129 citations · Full text

Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma

Adam L. Green, Shakti Ramkissoon, Dilara McCauley et al. · Neuro-Oncology · 2014 · 77 citations · Full text

PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer

Jessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant et al. · Cancer Research · 2017 · 39 citations · Full text

Rows per page

1–5 of 9